APOE E4 influences the manifestation of Alzheimer's Dementia in adults with Down's Syndrome

S Deb, J Braganza, N Norton, H Williams, PG Kehoe, J Williams, MJ Owen

Research output: Contribution to journalArticle (Academic Journal)peer-review

49 Citations (Scopus)

Abstract

BACKGROUND: Recent studies of the relationship between the apolipoprotein E (APOE) gene and Alzheimer's disease in adults with Down's syndrome have revealed inconsistent results. AIMS: To assess the role of the APOE gene in the manifestation of Alzheimer's disease in adults with Down's syndrome. METHOD: We studied the APOE genotypes of 24 adults with dementia and 33 non-demented adults with Down's syndrome over 35 years of age, and an additional group of 164 non-learning disabled adults. We also carried out a meta-analysis of all previously published studies of association between APOE and Down's syndrome, incorporating the current data. RESULTS: We observed a non-significant excess of APOE epsilon 4 and a reduction of epsilon 2 in adults with dementia compared with non-demented adults with Down's syndrome in our sample. However, meta-analysis showed a significantly higher frequency of epsilon 4 in adults with dementia compared with non-demented adults with Down's syndrome (odds ratio = 2.02, 95% CI 1.33-3.07, P = 0.001), but no significant reduction in the frequency of epsilon 2. CONCLUSIONS: The APOE epsilon 4 allele acts as a risk factor for the age-specific manifestation of Alzheimer's disease in people with Down's syndrome.
Translated title of the contributionAPOE E4 influences the manifestation of Alzheimer's Dementia in adults with Down's Syndrome
Original languageEnglish
Pages (from-to)468 - 472
Number of pages5
JournalBritish Journal of Psychiatry
Volume176
DOIs
Publication statusPublished - May 2000

Fingerprint

Dive into the research topics of 'APOE E4 influences the manifestation of Alzheimer's Dementia in adults with Down's Syndrome'. Together they form a unique fingerprint.

Cite this